Buscador de publicaciones
Mostrando 496 a 510 de 1626 publicaciones.
- Sabaté M, Brugaletta S, Abizaid A, Banning A, Bartorelli A, Džavík V, Ellis S, Holmes D, Gao R, Jeong MH, Legrand V, Neumann FJ, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P. Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.
Int. J. Cardiol. 2013 Oct; 168(3): 2522-7
IF: 5.509, Cuartil: 1
- Sambola A, Montoro JB, Del Blanco BG, Llavero N, Barrabés JA, Alfonso F, Bueno H, Cequier A, Serra A, Zueco J, Sabaté M, Rodríguez-Leor O, García-Dorado D. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
Am. Heart J. 2013 Oct; 166(4): 669-75
IF: 4.493, Cuartil: 1
- Erdmann J, Stark K, Esslinger UB, Rumpf PM, Koesling D, de Wit C, Kaiser FJ, Braunholz D, Medack A, Fischer M, Zimmermann ME, Tennstedt S, Graf E, Eck S, Aherrahrou Z, Nahrstaedt J, Willenborg C, Bruse P, Brænne I, Nöthen MM, Hofmann P, Braund PS, Mergia E, Reinhard W, Burgdorf C, Schreiber S, Balmforth AJ, Hall AS, Bertram L, Steinhagen-Thiessen E, Li SC, März W, Reilly M, Kathiresan S, McPherson R, Walter U, Ott J, Samani NJ, Strom TM, Meitinger T, Hengstenberg C, Schunkert H. Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Nature 2013 Dec; 504(7480): 432-6
IF: 38.597, Cuartil: 1, Decil: 1
- García-de-la-Mària C, Pericàs JM, del Rio A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
Antimicrob. Agents Chemother. 2013 May; 57(5): 2319-25
IF: 4.565, Cuartil: 1
- Merlos P, Núñez J, Sanchis J, Miñana G, Palau P, Bodí V, Husser O, Santas E, Bondanza L, Chorro FJ. Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications.
Eur. J. Intern. Med. 2013 Sep; 24(6): 562-7
IF: 2.049, Cuartil: 2
- Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, Garcia-Alvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernandez-Jimenez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Perez de Prado A, Fernández-Campos MJ, Casado I, Garcia-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Circulation 2013 Oct; 128(14): 1495-503
IF: 15.202, Cuartil: 1, Decil: 1
- Lopez-Palop R, Carrillo P, Cordero A, Frutos A, Mateo I, Mashlab S, Roldán J. Effect of lesion length on functional significance of intermediate long coronary lesions.
Catheter Cardiovasc Interv 2013 Mar; 81(4): E186-94
IF: 2.514, Cuartil: 2
- Orozco-Beltran D, Ruescas-Escolano E, Navarro-Palazón AI, Cordero A, Gaubert-Tortosa M, Navarro-Perez J, Carratalá-Munuera C, Pertusa-Martínez S, Soler-Bahilo E, Brotons-Muntó F, Bort-Cubero J, Nuñez-Martinez MA, Bertomeu-Martínez V, Gil-Guillen VF. Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial.
BMC Health Serv Res 2013; 13: 293
IF: 1.773, Cuartil: 2
- Martí JD, Li Bassi G, Rigol M, Saucedo L, Ranzani OT, Esperatti M, Luque N, Ferrer M, Vilaro J, Kolobow T, Torres A. Effects of manual rib cage compressions on expiratory flow and mucus clearance during mechanical ventilation.
Crit. Care Med. 2013 Mar; 41(3): 850-6
IF: 6.124, Cuartil: 1, Decil: 1
- Zarzuelo MJ, Gómez-Guzmán M, Jimenez R, Quintela AM, Romero M, Sánchez M, Zarzuelo A, Tamargo J, Perez-Vizcaino F, Duarte J. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.
Cardiovasc. Res. 2013 Sep; 99(4): 622-31
IF: 5.94, Cuartil: 1, Decil: 1
- D'Imperio H, Sanchis J, Núñez E, Núñez J. Effects of pitavastin in Japanese patients with chronic heart failure.
Circ. J. 2013; 77(8): 2204
IF: 3.578, Cuartil: 2
- Sala-Vila A, Cofán M, Mateo-Gallego R, Cenarro A, Civeira F, Ros E. Eicosapentaenoic acid in serum phospholipids relates to a less atherogenic lipoprotein profile in subjects with familial hypercholesterolemia.
J. Nutr. Biochem. 2013 Sep; 24(9): 1604-8
IF: 4.552, Cuartil: 1
- Husser O, Holzamer A, Philipp A, Nunez J, Bodí V, Müller T, Lubnow M, Luchner A, Lunz D, Riegger GA, Schmid C, Hengstenberg C, Hilker M. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation.
Catheter Cardiovasc Interv 2013 Oct; 82(4): E542-51
IF: 2.396, Cuartil: 2
- Bosch X, Rovira M, Sitges M, Domènech A, Ortiz-Pérez JT, de Caralt TM, Morales-Ruiz M, Perea RJ, Monzó M, Esteve J. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
J. Am. Coll. Cardiol. 2013 Jun; 61(23): 2355-62
IF: 14.086, Cuartil: 1, Decil: 1
- Tarín JJ, Hermenegildo C, García-Pérez MA, Cano A. Endocrinology and physiology of pseudocyesis.
Reprod. Biol. Endocrinol. 2013; 11: 39
IF: 2.144, Cuartil: 3
Una iniciativa de
